What we discuss:
Why it’s important:
In the excitement of the psychedelic renaissance, it can feel like all of this is “new.” It’s often said that there isn't enough research to support the use of ibogaine in a clinical setting, but Dr. Mash’s work is part of a growing body of evidence that proves otherwise. Reconciling her work and the stories you’ve heard on this show with the fact that ibogaine is still a Schedule I substance in the United States – meaning it has no medical value and a high potential for abuse – is hard to do. Understanding and working to change drug policy through research is a long game. We’re lucky that an expert like Dr. Mash is staying on the field.
Can the psychedelic ibogaine really get to the root of trauma? In Ibogaine Uncovered, author and journalist Amanda Siebert explores the impact of this powerful medicine including what prompts people to seek it out and how their lives are often transformed through the teachings they receive. Guests take an honest look at their healing journey, unpacking their lived experiences with substance use disorder, complex trauma, depression, anxiety, eating disorders, and grief. Expert guests also provide listeners with wisdom for their own healing journey. Join Siebert for powerful conversations that highlight the value of preparation, integration, and community in the world of ibogaine healing.
